PARP1 and cancer: In order to determine whether the reduction in the intracellular amastigotes was due to inhibition of TcPARP or hPARP-1, infection experiments were carried out on monolayers of human A549 cancer cells and on A549 cells where hPARP-1 was silenced by iRNA (sh_PARP).